PXMVF News and Press, Pixium Vision From 05/10/23

Pixium Vision convenes its Annual Meeting of Shareholders on June 13 , 2023 Paris, France, May 10 , 202 3 – 07:00 p.m. CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovati...

Pixium Vision announces the availability of its annual report for the financial year 202 2 Paris, April 25 , 202 3 – 7.00 p.m. CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innov...

Pixium Vision announces its consolidated financial statements for the financial year 202 2 and the consolidated cash balance for March 31 , 2023 Paris, April 21 , 202 3 – 7.00 a.m. CET - Pixium Vision SA (Euron...

Communication following the announcemen t of FDA Breakthrough Device Designation for the Prima System in Dry AMD Conversion of 160 ORNAN2022 by ESGO with intention to pursue controlled trading of shares Cost reduction measures implemented potentially extending the ...

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD Pixium Vision to receive interactive communication with FDA through premarket review phase of Prima System and potential prioritized regulatory review Breakthrough Device Designation aims t...

Reduction of share capital due to losses by reduction of nominal value: number of shares unchanged Paris, France, March 17 , 2023 – 07:00 CET – The Board of Directors of the Company decided at its meeting of March 16, 2023, to implement the authorization grante...

Results of Extraordinary Shareholder s Meeting held on March 8, 2023 Paris, France, March 10 , 202 3 – 19:00 CET – The Extraordinary Shareholders Meeting of Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bio...

Extraordinary Shareholder Meeting of March 8 , 2023: Notice of publication of the preparatory documents Paris, France, February 2 8 , 2023 – 19.00 am CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics com...

Second convening of the Extraordinary Shareholder Meeting on March 8, 2023 Paris, France, February 16 , 2023 – 6.00 pm CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovati...

Pixium Vision announces its cash position at 31 December 202 2 and provides an update on its activities. Paris, 14 February 202 3 – 21:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bioelectronics compa...